Role ofTP53mutations in triple negative and HER2-positive breast cancer treated with neoadjuvant anthracycline/taxane-based chemotherapy-Reference-Cited by-同舟云学术

Role ofTP53mutations in triple negative and HER2-positive breast cancer treated with neoadjuvant anthracycline/taxane-based chemotherapy

Published:2016-09-07 Issue:42 Volume:7 Page:67686-67698
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Darb-Esfahani Silvia¹,Denkert Carsten¹²,Stenzinger Albrecht³⁴,Salat Christoph⁵,Sinn Bruno¹,Schem Christian⁶,Endris Volker³,Klare Peter⁷,Schmitt Wolfgang¹,Blohmer Jens-Uwe⁸,Weichert Wilko²⁹,Möbs Markus¹,Tesch Hans¹⁰,Kümmel Sherko¹¹,Sinn Peter³,Jackisch Christian¹²,Dietel Manfred¹,Reimer Toralf¹³,Loi Sherene¹⁴,Untch Michael¹⁵,von Minckwitz Gunter¹⁶,Nekljudova Valentina¹⁶,Loibl Sibylle¹⁶

Affiliation:

1. Institute of Pathology, Charité Universitätsmedizin Berlin, Berlin, Germany

2. German Cancer Consortium, (DKTK), Berlin, Germany

3. Institute of Pathology, University Hospital Heidelberg, Heidelberg, Germany

4. Department of Pathology, Center for Integrated Diagnostics (CID), Massachusetts General Hospital, Boston, MA, USA

5. Hämatoonkologische Schwerpunktpraxis, Munich, Germany

6. Department of Gynecology and Obstetrics, University Hospital Schleswig-Hostein, Kiel, Germany

7. Praxisklinik Krebsheilkunde für Frauen/Brustzentrum, Berlin, Germany

8. Department of Gynecology and Obstetrics, Charité Universitätsmedizin Berlin, Berlin, Germany

9. Institute of Pathology, Technical University Munich, Munich, Germany

10. Center for Hematology and Oncology Bethanien, Frankfurt/Main, Germany

11. Breast Unit, Kliniken Essen Mitte, Essen, Germany

12. Department of Gynecology and Obstetrics, Sana Klinikum Offenbach, Offenbach, Germany

13. Department of Gynecology, Klinikum Südstadt Rostock, Rostock, Germany

14. Peter MacCallum Cancer Centre, East Melbourne, Victoria, Australia

15. Department of Gynecology and Obstetrics, Helios Klinikum Berlin-Buch, Berlin, Germany

16. German Breast Group c/o (GBG Forschungs GmbH), Neu-Isenburg, Germany

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 51 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Neoadjuvant talazoparib in patients with germline BRCA1/2 mutation-positive, early-stage triple-negative breast cancer: exploration of tumor BRCA mutational status;Breast Cancer;2024-06-13

2. Impact of Neoadjuvant Chemotherapy (NAC) on Biomarker Expression in Breast Cancer;Medicina;2024-04-29

3. Variation Analysis in Premenopausal and Postmenopausal Breast Cancer Cases;Journal of Personalized Medicine;2024-04-20

4. Mechanistic Investigation of Thiazole-Based Pyruvate Kinase M2 Inhibitor Causing Tumor Regression in Triple-Negative Breast Cancer;Journal of Medicinal Chemistry;2024-02-26

5. Predictive markers for pathological complete response (pCR) after neo-adjuvant chemotherapy in HER2-positive breast carcinoma;HISTOL HISTOPATHOL;2024